Robert Sidbury MD, MPH, FAAD

Robert Sidbury MD, MPH got his undergraduate and medical degrees from Duke University and his Masters in Public Health from Harvard. He did his internship and residency at UCSF and the Oregon Health and Science University and completed fellowships at Northwestern University and Harvard.

He has held faculty positions at Harvard Medical School and the University of Washington School of Medicine where he is currently Professor in the Department of Pediatrics and Chief of the Division of Dermatology. His clinical and research interests include atopic dermatitis, vascular tumors of infancy, vitamin D, and pediatric health services.

Dr. Sidbury is currently site PI for clinical trials of biologic medications for AD including dupilumab and nemolizumab, as well as a trial of a topical anticholinergic agent for hyperhidrosis. Past trials have focused on epidermolysis bullosa, hemangiomas, among other diseases.